Information for healthcare providers on obtaining and using TPOXX (Tecovirimat) for treatment of monkeypox

i

Information for healthcare providers on obtaining and using TPOXX (Tecovirimat) for treatment of monkeypox

Supporting Files Public Domain

File Language:

English

Details

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
Description:

Updated August 18, 2022

CDC, in partnership with FDA, has made it easier for healthcare providers to provide tecovirimat (TPOXX) treatment to patients with monkeypox under EA-IND. The streamlined process reduces the number of required forms and gives patients the option to see their doctor virtually.
Content Notes:

How to obtain TPOXX -- Protocol -- Required -- Optional -- Institutional Review Board (IRB) Approval
Subjects:

Antiviral Agents Drugs, Investigational Mpox (monkeypox) Poxviridae Infections/drug Therapy Smallpox/drug Therapy
Document Type:

Webpage
Name as Subject:

Tecovirimat ; Tecovirimat
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:3368c67ef021f81f10ad5884d7c6ef1949b1bc1a16cdb9aa88639e15b4efe913
Download URL:

https://stacks.cdc.gov/view/cdc/120465/cdc_120465_DS1.pdf
File Type:

[PDF - 410.90 KB ]

obtaining-tecovirimat.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.